243 related articles for article (PubMed ID: 35553369)
21. Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Matsumoto K; Fujimori N; Hata Y; Minoda Y; Murakami M; Teramatsu K; Takamatsu Y; Takeno A; Oono T; Ihara E; Nakata K; Nakamura M; Yamamoto T; Koga Y; Oda Y; Ito T; Ogawa Y
Dig Dis; 2023; 41(2):316-324. PubMed ID: 35588707
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
23. NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?
Dinu A; Aschie M; Cozaru GC; Mitroi AF; Grasa CN; Iordache IE; Deacu M; Orasanu CI; Nicolau AA; Baltatescu GI
J Gastrointestin Liver Dis; 2023 Jun; 32(2):162-169. PubMed ID: 37345605
[TBL] [Abstract][Full Text] [Related]
24. Impact of tumor grade on pancreatic neuroendocrine tumors.
Shyr BS; Shyr BU; Chen SC; Shyr YM; Wang SE
Asian J Surg; 2022 Dec; 45(12):2659-2663. PubMed ID: 35246343
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms.
Huang PY; Tsai KL; Liang CM; Tai WC; Rau KM; Wu KL; Huang CC; Chuah SK
Kaohsiung J Med Sci; 2018 Nov; 34(11):650-656. PubMed ID: 30392572
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
[TBL] [Abstract][Full Text] [Related]
27. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
28. Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification.
Yang M; Zeng L; Hou SZ; Ke NW; Tian BL; Liu XB; Xiang B; Zhang Y
J Oncol; 2020; 2020():6572398. PubMed ID: 33014053
[TBL] [Abstract][Full Text] [Related]
29. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.
Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y
J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.
Chen L; Zhou L; Zhang M; Shang L; Zhang P; Wang W; Fang C; Li J; Xu T; Tan H; Zhang P; Qiu M; Yu X; Jin K; Chen Y; Chen H; Lin R; Zhang Q; Shen L; Chen M; Li J; Li L; Chen J
BMC Cancer; 2017 Aug; 17(1):521. PubMed ID: 28778195
[TBL] [Abstract][Full Text] [Related]
32. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.
Liu M; Li N; Tang H; Chen L; Liu X; Wang Y; Lin Y; Luo Y; Wei S; Wen W; Chen M; Wang J; Zhang N; Chen J
Oncologist; 2023 Sep; 28(9):e723-e736. PubMed ID: 37086484
[TBL] [Abstract][Full Text] [Related]
33. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
[TBL] [Abstract][Full Text] [Related]
34. Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation.
Su W; Yang K; Jiang H; Song H; Feng K; Li Q
Virchows Arch; 2022 Sep; 481(3):433-441. PubMed ID: 35913578
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
[TBL] [Abstract][Full Text] [Related]
36. CT evaluation of gastroenteric neuroendocrine tumors: relationship between ct features and the pathologic classification.
Feng ST; Luo Y; Chan T; Peng Z; Chen J; Chen M; Li ZP
AJR Am J Roentgenol; 2014 Sep; 203(3):W260-6. PubMed ID: 25148182
[TBL] [Abstract][Full Text] [Related]
37. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
[TBL] [Abstract][Full Text] [Related]
38. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
39. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
[TBL] [Abstract][Full Text] [Related]
40. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021.
Thiis-Evensen E; Boyar Cetinkaya R
J Neuroendocrinol; 2023 Apr; 35(4):e13264. PubMed ID: 36988112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
